Objectives: To investigate the association between high-fluorescence lymphocyte cell (HFLC) and atypical lymphocyte (AL) counts, and to determine the clinical significance of HFLC.
from mature lymphocytes by their heterogeneity in size and shape. Characteristics of one AL may differ from those of other ALs in the same blood smear. Several AL subtypes have been described, including Downey type I, Downey type II, Downey type III, and plasmacytoid lymphocyte. 2 As a result of these variations, accurate enumeration of ALs can be challenging in routine clinical practice. Most routinely used automated hematology analyzers cannot perform an accurate AL count; however, they are designed to generate a flag to alert laboratory staff to the presence of ALs in a specimen. Then, a manual microscopic count is performed to estimate the AL count. This manual counting method is widely used in most clinical laboratories because blood smear preparation is inexpensive and easy to perform. However, manual AL counting requires examiner expertise to produce an accurate result; variability in results may occur among examiners due to examiner subjectivity. 4 Manual AL counting is also timeand labor-intensive.
High fluorescence lymphocyte cell (HFLC) count is a hematologic research marker that can be analyzed using an automated instrument. HFLC count reveals a cell population that can be distinguished from monocytes and normal lymphocytes in a 5-part differential channel by the higher intensity of their fluorescent signals. Previous studies 5, 6 demonstrated the correlation between HFLCs and activated B lymphocytes, and between HFLCs and plasma cells in peripheral blood. Because AL is a reactive form of lymphocyte that can be stimulated by immune processes, the number of HFLCs may also correlate with that of AL. To our knowledge, no study has specifically investigated agreement between HFLC and manual microscopic AL counts, and the clinical significance of HFLC count. Accordingly, the aim of this study was to investigate association between automated HFLC and AL counts. Further, the clinical significance of HFLC was determined.
Materials and Methods

Blood Specimens
We included a total of 320 blood specimens with various levels of HFLC from 0 to 3.4 × 10 9 per L in the study. These specimens were sent from inpatient and outpatient departments to the central laboratory at the Department of Clinical Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Dipotassium ethylenediaminetetraacetic acid (EDTA) tubes (VACUETTE; Greiner Bio-One International GmbH) were used for blood collection. Complete blood count (CBC), HFLC analysis, and blood-smear preparation were performed within 4 hours after blood collection. After automated analysis, specimens were further examined for microscopic AL count. The investigators were masked to CBC parameters and patient data; examinations included blood smears. After blood analysis was completed for each specimen, the principle diagnoses were reviewed and categorized into subgroups (ie, infectious diseases, immunological disorders, malignancies, and others). Diagnosis of infectious diseases required positive pathogen isolation, serologic testing, or specific antigen detection.
HFLC Count by Automated Hematology Analyzer
We used the Sysmex XN-3000 (Sysmex Corporation) to analyze blood count and HFLC in this study. This unit comprises 1 sampler, 2 Sysmex XN modular analyzers, and 1 Sysmex SP-10 slide maker and stainer (Sysmex Corporation). Only 1 selected Sysmex XN module was assessed. At least 3 mL of blood was mixed thoroughly before testing. The analyzer was operated in routine mode according to the manufacturer-provided instructions. HFLCs were analyzed in the WDF channel of the analyzer using polymethine fluorescent dye, with analysis based on the flow cytometry principle. HFLCs are located separately from monocytes and lymphocytes on the scattergram that is generated by the analyzer. The characteristic that distinguishes HFLCs from other cells is the high intensity of their fluorescent signal, which reflects an abundance of RNA content in HFLCs.
Three levels of internal quality control (IQC) materials were regularly evaluated for all routine hematologic parameters. The Sysmex analyzer used in this study was included as a participating automated analyzer in the College of American Pathologists (CAP) External Quality Assurance (EQA) scheme for CBC testing. Required analyzer maintenance procedures were performed regularly during the course of the study.
Reproducibility of HFLC Count
We used 4 specimens with different levels of HFLC counts to assess the intra-assay reproducibility of HFLC testing. Each specimen was analyzed repeatedly in the automatic routine mode for 10 measurements. Then, percentages of coefficient of variation (%CVs) were calculated using the equation %CV = (SD/Mean) × 100.
Manual Microscopic AL Count
Blood smears were prepared using a Sysmex SP-10 fully automated slide maker and stainer (Sysmex Corporation) that used Wright-Giemsa reagents (YD Diagnostics) for the staining process. Each included smear was examined by 2 experienced laboratory staff members (C.T. and C. 
Results
Reproducibility of HFLC Counts and Comparison between HFLC and AL Counts
The %CVs of evaluated specimens at various levels of HFLC counts are shown in Table 1 . Absolute counts and percentages of HFLCs and ALs were compared. PassingBablok regression analysis and r s between HFLC counts and AL counts are shown in Figure 1 . Test characteristics including sensitivity, specificity, and accuracy of HFLC for the detection of AL in peripheral blood at the appropriate cutoff values of HFLC (0.1 × 10 9 /L and 1.5%) are shown in Table 2 .
Clinical Significance of HFLC
Patients were categorized into 4 groups according to principal diagnosis. Group 1 included patients with infectious diseases, including viral, bacterial, fungal, and tuberculous infections. In this group, the proportion of patients with dengue infection was 67.7% (155/229). A box-whisker plot of HFLC counts of patients with dengue infection and patients with infectious diseases other than dengue is shown in Figure 2 . Group 2 included patients with autoimmune disorders and drug allergies. Group 3 included patients with solid or hematologic malignant neoplasms. Two patients in group 3 had acute leukemia. Group 4 included healthy persons and patients with diseases or disorders other than those included in groups 1 to 3 (eg, hypertension, diabetes mellitus, chronic kidney disease, coronary artery disease, stroke, cirrhosis, cataract, thalassemia). Comparison of demographic data, WBC, AL, and HFLC counts are shown in Table 3 .
Discussion
In the present study, the percentage CVs of automated HFLC counts at various levels were acceptable, comparing with values from a previous study. 5 For comparison, we found that automated HFLC counts were well correlated with AL counts by manual microscopic method for absolute counts and percentages, with the r s values of 0.865 and 0.893, respectively. This finding may be explained by the property of fluorescent dye in HFLC analysis, which stains RNA content in stimulated ALs. Although ALs from peripheral-blood-smear examination generally include B lymphocytes and cytotoxic T-lymphocytes, most HFLCs may represent only antibody-producing B-lymphocytes, as proposed by Linssen et al. 5 Although we observed good correlation between
HFLCs and ALs in this study, HFLC counts were not in perfect agreement with AL counts in Passing-Bablok analysis. There was no statistically significant constant error; however, proportional errors were found between methods. This finding may be explained by a higher rate of detection in HFLCs, which are detected by their high fluorescent signals, than in ALs, which require manual microscopic detection by laboratory staff that is based on the obvious characteristics of each cell. However, this potential bias between methods may not be clinically significant.
Using the presence of ALs in peripheral blood as a criterion standard, the HFLC cutoff values of 0.1 × 10 9 per L and 1.5% yielded high sensitivity, specificity, and accuracy for the detection of ALs. Absolute and percentage counts can be used in this situation because performances of both parameters were comparable. Applying an HFLC alert flag at these cutoff values as part of peripheral-blood-smear criteria may alert laboratory staff to be aware of ALs in specimens. Then, these data can be combined with other patient clinical data to determine specific diagnostic work-ups for suspected diseases.
Previous studies have investigated the diagnostic value of an automated flagging system for presence of ALs and HFLCs. Brigden et al 8 evaluated the performance of automated analyzers in patients with infectious mononucleosis and found that AL flagging generated high specificity for prediction of heterophile-positive status. Arneth 
Figure 2
Box-whisker plot of high fluorescence lymphocyte cell (HFLC) counts of patients with dengue infection and patients with infectious diseases other than dengue.
et al 9 studied HFLC counts in patients being treated in the intensive care unit (ICU) and reported that the number of HFLCs was higher in patients with sepsis than in patients without infection. To our knowledge, no study has investigated the relationship between HFLCs and a specific type of disease.
In the present study, we included patients with various conditions and found that HFLC count was highest in patients with infectious diseases (group 1 patients), compared with other patients. HFLC counts were not significantly different among patients with immunological disorders, malignant neoplasms, and other conditions. The disease most often encountered in the infectious group was dengue infection. This infection is very prevalent in tropical and subtropical areas and is classified as a major threat to public health. [10] [11] [12] Although a wide spectrum of WBC change can occur during dengue infection, the presence of AL in peripheral blood can support the diagnosis of dengue infection and predict disease severity. 13 Given that HFLC count was significantly correlated with AL count, the HFLC count should also have diagnostic value for dengue-infection diagnosis. In the present study, patients with dengue infection had significantly higher HFLC counts than patients with other infections. In endemic areas of dengue infection, reporting of HFLC counts, along with other hematologic parameters, may help physicians decide on specific investigations to facilitate definite diagnosis. Although HFLC can be automatically analyzed by routine CBC mode without additional reagent use, it is not routinely reported in the CBC result by most clinical laboratories. Currently, Sysmex Corporation, which manufactures the instrument we used in our testing, recommends that HFLC is useful as a research parameter. Lack of specific reference range and an external quality-assurance scheme limit the use of HFLC in routine laboratory practice. Few data regarding diagnostic value of HFLC are available. Extended studies about the test characteristics of HFLC should be further investigated, to elucidate the diagnostic value of HFLC count for diagnosis of specific diseases. LM 
